Clinical Features	Time to Death		AGE		NEOPLASM.DISEASESTAGE		PATHOLOGY.T.STAGE		PATHOLOGY.N.STAGE		PATHOLOGY.M.STAGE		GENDER		HISTOLOGICAL.TYPE		RADIATIONS.RADIATION.REGIMENINDICATION		RADIATIONEXPOSURE		EXTRATHYROIDAL.EXTENSION		COMPLETENESS.OF.RESECTION		NUMBER.OF.LYMPH.NODES		MULTIFOCALITY		TUMOR.SIZE	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	t-test_P	t-test_Q	Chi-square test_P	Chi-square test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q	t-test_P	t-test_Q
NRAS	32 (8%)	353	0.47787	1	0.74775	1	0.043637	1	0.078837	1	0.00041298	0.0409	0.34771	1	0.67417	1	1.5469e-05	0.00156	0.6099	1	1	1	0.10516	1	0.73907	1	0.00011259	0.0113	0.19448	1	0.8513	1
BRAF	232 (60%)	153	0.80619	1	0.84808	1	0.0024544	0.236	0.00084917	0.0832	0.00090461	0.0877	0.067158	1	0.55163	1	5.4273e-20	5.59e-18	0.032298	1	0.5908	1	2.0876e-07	2.13e-05	0.58709	1	0.61807	1	0.75159	1	0.23136	1
HRAS	13 (3%)	372	0.51992	1	0.61609	1	0.33859	1	0.43643	1	0.54852	1	0.2619	1	0.74508	1	0.014679	1	1	1	1	1	0.68126	1	0.13725	1	0.51048	1	0.77854	1	0.93308	1
OTUD4	5 (1%)	380	0.64986	1	0.70869	1	0.9115	1	1	1	0.67085	1	0.24122	1	0.33638	1	0.43578	1	1	1	1	1	0.67008	1	1	1	0.0062863	0.597	0.66709	1	NA	NA
EIF1AX	6 (2%)	379	0.079595	1	0.13459	1	0.96947	1	1	1	0.62488	1	0.46808	1	0.17098	1	0.092152	1	1	1	1	1	1	1	0.25464	1	0.77079	1	0.66709	1	0.67239	1
NUP93	4 (1%)	381	0.90741	1	0.39116	1	0.79442	1	0.73078	1	0.34855	1	0.65326	1	1	1	0.015692	1	1	1	1	1	1	1	0.49765	1	0.6093	1	0.34191	1	0.99512	1
NLRP6	3 (1%)	382	0.65537	1	0.034151	1	0.815	1	0.15724	1	0.6052	1	0.13218	1	1	1	0.66761	1	1	1	1	1	1	1	1	1	0.52479	1	0.59978	1	NA	NA